Consistently, treatments with RGMa antibodies promoted axon regeneration and functional recovery in adult rodents with SCI and also showed a trend toward reducing CSPG expression around the lesion (Hata et al., 2006 ; Mothe et al., 2017 ).
← all excerpts
Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors.
1
—
—